Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.
暂无分享,去创建一个
S. Lippman | R. Lotan | W. Hong | Shi-Yong Sun | R. Lotan | S. Y. Sun | P. Yue | W. Li | W. Hong | Shi-Yong Sun | Wanbo Li | Waun Ki Hong | W. K. Hong
[1] R. Lotan,et al. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. , 1997, Cancer research.
[2] R. Lotan,et al. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. , 1997, Journal of the National Cancer Institute.
[3] E. Dmitrovsky. N-(4-hydroxyphenyl)retinamide activation of a distinct pathway signaling apoptosis. , 1997, Journal of the National Cancer Institute.
[4] John Calvin Reed,et al. Role of antioxidants and intracellular free radicals in retinamide-induced cell death. , 1997, Carcinogenesis.
[5] D. Fuchs,et al. Reactive Oxygen and Apoptosis , 1997 .
[6] G. Powis,et al. Redox signaling and the control of cell growth and death. , 1997, Advances in pharmacology.
[7] Y. Hiraku,et al. Oxidative DNA damage and apoptosis induced by benzene metabolites. , 1996, Cancer research.
[8] M. Takada,et al. Involvement of hydrogen peroxide production in erbstatin-induced apoptosis in human small cell lung carcinoma cells. , 1996, Cancer research.
[9] A. Fanjul,et al. 4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors* , 1996, The Journal of Biological Chemistry.
[10] P. Chambon. A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] R. Lotan,et al. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[12] S. Fujieda,et al. Involvement of intracellular glutathione in induction of apoptosis by cisplatin in a human pharyngeal carcinoma cell line. , 1996, Anticancer research.
[13] C. Lau,et al. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines. , 1996, Cancer research.
[14] F. Zunino,et al. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression , 1996, International journal of cancer.
[15] S. Orrenius,et al. Signalling mechanisms and oxidative stress in apoptosis. , 1995, Toxicology letters.
[16] S. Ramalingam,et al. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. , 1995, Journal of the National Cancer Institute.
[17] J. Lotem,et al. Thymic abnormalities and enhanced apoptosis of thymocytes and bone marrow cells in transgenic mice overexpressing Cu/Zn‐superoxide dismutase: implications for Down syndrome. , 1995, The EMBO journal.
[18] Z. Shao,et al. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. , 1995, Carcinogenesis.
[19] W. Hong,et al. Induction of apoptosis by retinoids in human cervical-carcinoma cell-lines. , 1995, International journal of oncology.
[20] S. Orrenius,et al. The role of intracellular oxidants in apoptosis. , 1995, Biochimica et biophysica acta.
[21] C. Boni,et al. Can fenretinide protect women against ovarian cancer? , 1995, Journal of the National Cancer Institute.
[22] G. Powis,et al. Redox signalling and the control of cell growth and death. , 1995, Pharmacology & therapeutics.
[23] John Calvin Reed,et al. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. , 1995, Blood.
[24] H. Namiki,et al. Apoptotic cell death induced by serum and its prevention by thiols , 1994, Journal of cellular physiology.
[25] U. Veronesi,et al. N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. , 1994, Journal of the National Cancer Institute.
[26] U. Veronesi,et al. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. , 1994, Cancer research.
[27] S. Ménard,et al. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. , 1993, Cancer research.
[28] D. Bredesen,et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. , 1993, Science.
[29] F. Formelli,et al. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity. , 1993, Cancer research.
[30] Z. Oltvai,et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.
[31] M. Clerici,et al. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] K. Pienta,et al. Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide. , 1993, Cancer research.
[33] M. Sporn,et al. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. , 1991, Cancer research.
[34] R. Mehta,et al. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor. , 1989, Carcinogenesis.
[35] W Malone,et al. Tolerability of the synthetic retinoid Fenretinide (HPR). , 1989, European journal of cancer & clinical oncology.